Skip to content

Mark Christopher Genovese, M.D.

NPI 1487711875ActiveIndividual· Internal Medicine, Rheumatology· Stanford, CA

Internal Medicine, Rheumatology (M.D.) in Stanford, California, trained at Johns Hopkins University School of Medicine (class of 1992). Part D covered 16 prescriptions written in 2024. Eli Lilly and Company reported $99.00 in payments in 2025, mostly education.

Overview

NPI1487711875
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorYes
NPI issuedJan 3, 2007
Last updated in NPPESApr 29, 2024
Certified by providerApr 29, 2024

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Rheumatology Primary207RR0500XA52149CA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Internal Medicine (CA)

Part D prescriptions in 2024

Prescriptions (claims)16 · 23 30-day fills
Total drug cost$56,813

Medicare sources and data years

Education and affiliations

Medical schoolJohns Hopkins University School of Medicine
Graduation year1992
Medicare specialtyInternal Medicine
Secondary specialtiesRheumatology
TelehealthOffers telehealth

Medical group

Hospital affiliation

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$99.00 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Eli Lilly and Company$99.001

What the 2025 payments were for

  • Education$99.00 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Rheumatology providers in Stanford

All Internal Medicine, Rheumatology providers in California →